Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2021 · 10-Q
Revenue—
Net Income-$2.72M-$2.72MN/M vs Q1 2020 EPS Diluted-$0.33-$0.33N/M vs Q1 2020 Operating Income-$2,479,000N/M Operating Cash Flow-$3,006,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$3,090,000N/M ended Mar 31, 2021 · filed Apr 22, 2021 · 22 d after period end